---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-103029"
form_type: "8-K"
ticker: "AMWL"
cik: "0001393584"
company_name: "American Well Corp"
filed_at: "2025-08-05T23:59:59+00:00"
generated_at: "2026-05-17T20:34:13.517328+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Amwell Q2 revenue $70.9M, net loss $19.5M; cuts FY2025 revenue guidance to $245M-$250M

## Summary
- Revenue $70.9M (subscription $40.4M, AMG visits $22.8M); gross margin 56.1%.
- Net loss $19.5M (vs $18.4M Q1); Adj. EBITDA loss improved to $4.7M from $12.2M Q1.
- Added Florida Blue health plan; extended US Defense Health Agency contract.
- FY2025 revenue guidance lowered to $245M-$250M from $250M-$260M; Adj. EBITDA narrowed to ($50M)-($45M).
- Q3 2025 guidance: revenue $53M-$56M, Adj. EBITDA loss ($15M)-($13M).

## SEC filing metadata
- accession: 0000950170-25-103029
- form_type: 8-K
- ticker: AMWL
- cik: 0001393584
- company_name: American Well Corp
- filed_at: 2025-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393584/000095017025103029/0000950170-25-103029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393584/000095017025103029/amwl-20250805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-103029
- JSON: https://secwatch.observer/filing/0000950170-25-103029.json
- Plain text: https://secwatch.observer/filing/0000950170-25-103029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
